MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $965,624 | -29.7% | 60,201 | +1.5% | 0.00% | -50.0% |
| Q2 2023 | $1,374,319 | -0.1% | 59,289 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $1,375,448 | +60.8% | 59,210 | +0.4% | 0.00% | +100.0% |
| Q4 2022 | $855,568 | -26.2% | 58,964 | -2.9% | 0.00% | 0.0% |
| Q3 2022 | $1,159,000 | +25.4% | 60,746 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $924,000 | -8.7% | 50,847 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $1,012,000 | -7.6% | 49,378 | +24.4% | 0.00% | 0.0% |
| Q4 2021 | $1,095,000 | +32.7% | 39,687 | +55.4% | 0.00% | 0.0% |
| Q3 2021 | $825,000 | -1.7% | 25,542 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $839,000 | +40.3% | 27,427 | +39.6% | 0.00% | 0.0% |
| Q1 2021 | $598,000 | +182.1% | 19,648 | +83.5% | 0.00% | – |
| Q4 2020 | $212,000 | -54.3% | 10,710 | -66.9% | 0.00% | – |
| Q1 2020 | $464,000 | +10.5% | 32,404 | +109.8% | 0.00% | -100.0% |
| Q4 2019 | $420,000 | +14.8% | 15,442 | +20.8% | 0.00% | – |
| Q3 2019 | $366,000 | +34.6% | 12,778 | +75.7% | 0.00% | -100.0% |
| Q2 2018 | $272,000 | +47.0% | 7,274 | +15.9% | 0.00% | – |
| Q1 2018 | $185,000 | +320.5% | 6,274 | +135.2% | 0.00% | – |
| Q4 2016 | $44,000 | -21.4% | 2,667 | -2.4% | 0.00% | – |
| Q3 2016 | $56,000 | -8.2% | 2,733 | +36.8% | 0.00% | – |
| Q2 2016 | $61,000 | +45.2% | 1,998 | +77.1% | 0.00% | – |
| Q1 2016 | $42,000 | -41.7% | 1,128 | -32.0% | 0.00% | – |
| Q4 2015 | $72,000 | +12.5% | 1,660 | -3.2% | 0.00% | – |
| Q3 2015 | $64,000 | +10.3% | 1,714 | +0.8% | 0.00% | – |
| Q2 2015 | $58,000 | – | 1,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |